WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
UN Human Rights Council calls for accountability for possible war crimes by IsraelSichuan beat Inner Mongolia to retain WCBA titleMalta marks World Tai Chi Day to embrace Chinese cultureChinese FM meets with Thai Princess Sirindhorn in BeijingIran vows 'harsher' response should Israel 'make another mistake'China stay perfect in Thomas & Uber CupSichuan beat Inner Mongolia to retain WCBA titleChina is committed to managing Ren'ai Jiao issue through dialogue and consultation: FM spokespersonKing Charles is keen to saddle up for Trooping The Colour as he returns to public duties this weekAuthorities name driver fatally shot by deputies in Memphis after he sped toward them